Oncogenic EGFR signaling greatly resulted in the expansion of alveolar macrophages (AMs; lung cancer tissue-resident macrophages) consistent with an M2-macrophage phenotype harboring reduced expression of costimulatory molecules, such as CD40, CD80, and CD86, as well as downregulated MHC-II expression (44). This evidence concerns the gene EGFR and lung cancer.